Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit
Clinical trial NCT01280565 · TERMINATED
Trial details
- NCT number
- NCT01280565
- Sponsor
- AB Science
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2019-08-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.